Skip to content

Clinical trials

Completed Phase 1 Macular Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Phase 1 Status: Completed Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20041
20053
20061
20078
20083
20092
20109
20111
20132
20146
20151
20162
20173
20183
20191
20202
20213
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)9
GlaxoSmithKline5
Alcon Research2
Allergan2
Novartis Pharmaceuticals2
Ophthotech Corporation2
Pfizer2
Washington University School of Medicine2
Adverum Biotechnologies, Inc.1
Alkeus Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration62
Choroidal Neovascularization14
Eye Diseases6
Retinal Degeneration6
Geographic Atrophy5
Retinal Diseases5
Macular Edema4
Wet Macular Degeneration4
Diabetic Retinopathy3
Retinal Vein Occlusion3

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.